Why is Emmessar Biotech falling/rising?

As of 23-Sep, Emmessar Biotech & Nutrition Ltd is currently priced at 35.30, reflecting a decline of 0.46, or 1.29%. The stock has been underperforming, having lost 10.41% over the last three days, and it is noted that it has underperformed its sector by 0.73% today. Despite trading above its moving averages across various time frames, the stock has seen a significant drop in investor participation, with delivery volume plummeting by 90.77% compared to the five-day average. Year-to-date, the stock is down 23.76%, contrasting with a 5.07% increase in the benchmark index, indicating a challenging performance relative to the market.
Broader Market Context: In the short term, Emmessar Biotech's performance has been relatively strong, with a 1-week return of 8.95%, while the Sensex has slightly declined by 0.34%. However, over the longer term, the stock's year-to-date decline of 23.76% starkly contrasts with the benchmark's positive return, suggesting that while there may be some recent momentum, the overall outlook remains negative. The broader market context indicates that despite some recent gains, the stock is struggling to maintain investor confidence, which is reflected in the declining trading volume and overall performance metrics.